미국의 카프노그래피 디바이스 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 솔루션 제공업체별, 기술별, 구성요소별, 용도별, 최종 용도별, 부문별 예측(2024-2030년)

U.S. Capnography Devices Market Growth & Trends:

The U.S. capnography devices market size is expected to reach USD 675.7 million by 2030, registering a CAGR of 7.35% from 2024 to 2030, according to a new report by Grand View Research, Inc. For instance, COPD drives the rising demand for capnography devices due to the need for continuous and accurate respiratory monitoring to manage and detect complications effectively. According to the CDC, in 2021, approximately 14.2 million U.S. adults had physician-diagnosed COPD. Capnography offers real-time assessment of ventilation status, crucial for early detection of respiratory distress and timely intervention in COPD patients. Hence, the need for better patient outcome and enhanced monitoring capabilities are driving the adoption of capnography devices in clinical settings.

Furthermore, COVID-19 contributed to the rising demand for capnography devices in the U.S. by highlighting the critical need for accurate and real-time respiratory monitoring in managing respiratory complications associated with the virus. The pandemic increased hospitalizations and the necessity for effective patient monitoring, especially for those on ventilators or experiencing severe respiratory issues. This surge in demand for enhanced respiratory care and monitoring capabilities significantly boosted the demand for capnography devices benefitting the market players financially. For instance, Masimo increased its product specific segment revenue to USD 1,239.2 million in 2021 from USD 829.9 million in 2018, reflecting a three-year CAGR of 14.3%. This growth is attributed to the expansion of its core SET pulse oximeter customer base, higher revenues from NomoLine capnography and rainbow Pulse CO-Oximetry, and an expanding list of OEM partners.

Furthermore, research indicates that capnography is increasingly important for both intubated and non-intubated patients, as it effectively measures and links to apneic events. Emerging studies are also exploring the combination of etCO2 and rSO2 to enhance the understanding of resuscitation. The technology is expanding, offering opportunities for broader application across the continuum of care, including emergency departments, pre-hospital settings, resuscitation response teams, critical care units, procedural sedation, general care floors, and pain management. Clinicians continue to rely on capnography to gain better insights into individual patient conditions, thereby driving the market in the U.S.

Moreover, market players undertake various growth strategies to grow and sustain in the U.S. capnography devices market. For instance, in June 2023, Royal Philips and Masimo received FDA clearance to activate Regional Oximetry (O3), SedLine Brain Function Monitoring, and CO? measurements in Philips IntelliVue MX850 and MX750 Patient Monitors. This extension of their collaboration allows clinicians to make quick, informed decisions without needing additional monitoring equipment.

U.S. Capnography Devices Market Report Highlights:

• On the basis of product, the portable segment dominated the market and held a revenue share of 57.97% in 2023. The growth is due to their versatility, ease of use, and ability to provide real-time respiratory monitoring across various clinical settings
• On the basis of solution offering, the integrated segment held the largest revenue share of over 58% in 2023. The growth is because these devices offer seamless integration with existing patient monitoring systems, providing comprehensive and continuous respiratory monitoring without the need for separate equipment
• On the basis of parameter, the single parameter segment held the largest revenue share of 52.17% in 2023. The segment growth can be attributed to affordable pricing of the product
• On the basis of technology, the microstream segment held the largest revenue share of over 37% in 2023. The segment growth is because the technology is feasible with both, intubated and non-intubated patients
• On the basis of component, the other accessories segment held the largest revenue share of 31.3% in 2023. The segment include several accessories, such as cuvettes, adaptors, masks, cables, and more, which are sold frequently
• On the basis of application, the procedural sedation segment held the largest revenue share of 24.58% in 2023. Capnography devices are essential for monitoring respiratory status and detecting early signs of respiratory compromise, which is particularly crucial during sedation when patients may experience reduced respiratory drive or airway obstruction, thereby driving the segment growth
• On the basis of end use, the hospitals segment held the largest revenue share of 45.67% in 2023. The growth is attributed to its extensive use of these devices across various departments and specialties within healthcare facilities

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Solution Offering
  • 1.1.3. Parameter
  • 1.1.4. Technology
  • 1.1.5. Component
  • 1.1.6. Application
  • 1.1.7. End use
  • 1.1.8. Estimates and forecast timeline.
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Solution offering outlook
  • 2.2.3. Parameter outlook
  • 2.2.4. Technology outlook
  • 2.2.5. Component Outlook
  • 2.2.6. Application type outlook
  • 2.2.7. End use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Capnography Devices Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. U.S. Capnography Devices Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. U.S. Capnography Devices Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2023 & 2030
• 4.2. Segment Dashboard
• 4.3. U.S. Capnography Devices Market by Product Outlook
• 4.4. Portable
  • 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 4.5. Stationary
  • 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. U.S. Capnography Devices Market: Solution Offering Estimates & Trend Analysis

• 5.1. Solution Offering Market Share, 2023 & 2030
• 5.2. Segment Dashboard
• 5.3. U.S. Capnography Devices Market by Solution Offering Outlook
• 5.4. Integrated
  • 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 5.5. Standalone
  • 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. U.S. Capnography Devices Market: Parameter Estimates & Trend Analysis

• 6.1. Parameter Market Share, 2023 & 2030
• 6.2. Segment Dashboard
• 6.3. U.S. Capnography Devices Market by Parameter Outlook
• 6.4. Single Parameter
  • 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 6.5. Multiparameter
  • 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. U.S. Capnography Devices Market: Technology Estimates & Trend Analysis

• 7.1. Technology Market Share, 2023 & 2030
• 7.2. Segment Dashboard
• 7.3. U.S. Capnography Devices Market by Technology Outlook
• 7.4. Mainstream
  • 7.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 7.5. Sidestream
  • 7.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 7.6. Microstream
  • 7.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 8. U.S. Capnography Devices Market: Component Estimates & Trend Analysis

• 8.1. Component Market Share, 2023 & 2030
• 8.2. Segment Dashboard
• 8.3. U.S. Capnography Devices Market by Component Outlook
• 8.4. OEM Modules
  • 8.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 8.5. Filters
  • 8.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 8.6. Sensors
  • 8.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 8.7. Sampling Line
  • 8.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 8.8. Other Accessories (Cuvettes, Adaptors, etc.)
  • 8.8.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 9. U.S. Capnography Devices Market: Application Estimates & Trend Analysis

• 9.1. Application Market Share, 2023 & 2030
• 9.2. Segment Dashboard
• 9.3. U.S. Capnography Devices Market by Application Outlook
• 9.4. Emergency Medicine
  • 9.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 9.5. Pain Medicine
  • 9.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 9.6. Procedural Sedation
  • 9.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 9.7. Critical Care
  • 9.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 9.8. Others
  • 9.8.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 10. U.S. Capnography Devices Market: End Use Estimates & Trend Analysis

• 10.1. End Use Market Share, 2023 & 2030
• 10.2. Segment Dashboard
• 10.3. U.S. Capnography Devices Market by End Use Outlook
• 10.4. Hospitals
  • 10.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 10.5. Ambulatory Care Centers
  • 10.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
• 10.6. Others
  • 10.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Recent Developments & Impact Analysis, By Key Market Participants
• 11.2. Company/Competition Categorization
• 11.3. Vendor Landscape
  • 11.3.1. Notable list of customers
  • 11.3.2. Key company market share analysis, 2023
  • 11.3.3. Koninklijke Philips N.V.
    • 11.3.3.1. Company overview
    • 11.3.3.2. Financial performance
    • 11.3.3.3. Technology Type benchmarking
    • 11.3.3.4. Strategic initiatives
  • 11.3.4. Infinium Medical, Inc.
    • 11.3.4.1. Company overview
    • 11.3.4.2. Financial performance
    • 11.3.4.3. Technology Type benchmarking
    • 11.3.4.4. Strategic initiatives
  • 11.3.5. Masimo
    • 11.3.5.1. Company overview
    • 11.3.5.2. Financial performance
    • 11.3.5.3. Technology Type benchmarking
    • 11.3.5.4. Strategic initiatives
  • 11.3.6. Medtronic
    • 11.3.6.1. Company overview
    • 11.3.6.2. Financial performance
    • 11.3.6.3. Technology Type benchmarking
    • 11.3.6.4. Strategic initiatives
  • 11.3.7. Nihon Kohden Corporation
    • 11.3.7.1. Company overview
    • 11.3.7.2. Financial performance
    • 11.3.7.3. Technology Type benchmarking
    • 11.3.7.4. Strategic initiatives
  • 11.3.8. ICU Medical Inc.
    • 11.3.8.1. Company overview
    • 11.3.8.2. Financial performance
    • 11.3.8.3. Technology Type benchmarking
    • 11.3.8.4. Strategic initiatives
  • 11.3.9. Nonin
    • 11.3.9.1. Company overview
    • 11.3.9.2. Financial performance
    • 11.3.9.3. Technology Type benchmarking
    • 11.3.9.4. Strategic initiatives
  • 11.3.10. BD
    • 11.3.10.1. Company overview
    • 11.3.10.2. Financial performance
    • 11.3.10.3. Technology Type benchmarking
    • 11.3.10.4. Strategic initiatives
  • 11.3.11. EdanUSA
    • 11.3.11.1. Company overview
    • 11.3.11.2. Financial performance
    • 11.3.11.3. Technology Type benchmarking
    • 11.3.11.4. Strategic initiatives
  • 11.3.12. Avante Health Solutions
    • 11.3.12.1. Company overview
    • 11.3.12.2. Financial performance
    • 11.3.12.3. Technology Type benchmarking
    • 11.3.12.4. Strategic initiatives
  • 11.3.13. Dragerwerk AG & Co. KGaA
    • 11.3.13.1. Company overview
    • 11.3.13.2. Financial performance
    • 11.3.13.3. Technology Type benchmarking
    • 11.3.13.4. Strategic initiatives